Patent Assignment
Reel/Frame 054578/0299
Assignment of Assignor's Interest
Recorded: 2020-12-08
Pages: 20
Assignor
OSIRIS THERAPEUTICS, INC.
Executed: 2013-10-10
Assignee
MESOBLAST INTERNATIONAL SÀRL
ROUTE DE PRE-BOIS 20, 1217 MEYRIN, SWITZERLAND
Covered Property
(1)
Mesenchymal Stem Cells Expressing TNF-alpha Receptors
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 8, 2020
From: DANILKOVITCH, ALLA; CARTER, DIANE; TYRELL, ALICIA; BUBNIC, SIMON
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 054578/0101 →
Security Interest
Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Release of Security Interest in Intellectual Property
Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →